BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 1.6% of their position (6.44K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $193.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/8/2026ACC: 0001820885-26-000025
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-6.44K
Net shares
Net seller
$193.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.44K
Price / share
$30.00
Trade value
$193.32K
% of position
1.6%
10/6/2026
395.79K→389.35K
Total
Net shares
−6.44K
Net value
-$193.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/6/2026 | S · Sale | −6.44K | $30.00 | $193.32K | 1.6% | 395.79K | 389.35K |
| Total | −6.44K | -$193.32K | ||||||
Derivative Transactions0
No derivative transactions reported